$ARRY

Jefferies resumes Array Technologies stock coverage with buy rating

Jefferies resumed coverage on Array Technologies (ARRY) with a buy rating and $7.00 price target, citing undervaluation and growth potential. Shares have fallen over 40% in six months. ARRY reported Q2 2026 earnings of $0.24 EPS on $342.1M revenue, beating estimates. UBS downgraded ARRY to Neutral with a $5.00 target, citing cash flow concerns.

Original reporting
Published Sep 29, 2026, 12:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 29, 2026, 1:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$ARRY
Bullish
medium confidence
Mentioned
$ARRY
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$ARRYBullishMed
01

Why it matters

Analyst coverage resumption and earnings beat provide fresh catalyst for a short‑term rally, but cash‑flow concerns remain.

02

Market read

New analyst endorsement and earnings beat could trigger buying interest in ARRY and related clean‑energy stocks.

03

What to watch

Potential execution risk in meeting the large Q4 target and the impact of UBS downgrade may temper upside.

Relevance 6/10Novelty 6/10Timing: today

Background

Array Technologies is a solar‑tracker manufacturer that has struggled with a 40% share decline over six months amid sector weakness.

Company-level read

Ticker impact

$ARRYBullishMedium confidence
Context

Jefferies resumed coverage on Array Technologies with a buy rating and a new $7 price target, citing Q2 earnings beat and a record $2.5B orderbook.

Expected impact

likely upward pressure as the market prices in the higher target and improved earnings outlook

Evidence & confidence

Buy rating and $7 target are above the current $3.83 price; Q2 results beat expectations, supporting a rally.

Market effects

Positive for solar tracker and broader clean‑energy equipment sector as the upgrade may lift peers.

U.S. clean‑energy equities could see modest gains.

Limited to investors tracking renewable‑energy supply chain.

Counterpoint

The preferred equity payment risk and transition to cash dividends could pressure cash flow, making the buy rating premature.

Key entities

  • Jefferies

    Resumed coverage with buy rating and $7 target.

  • UBS

    Downgraded to neutral, lowering its target to $5.

Related articles

$ARRYMed

Why Array (ARRY) Shares Are Plunging Today

Array Technologies (ARRY) shares fell 6.4% after UBS analyst Jon Windham downgraded the stock to Neutral and cut the price target to $5.00. The company's stock is down 58.4% year-to-date and 66.3% below its 52-week high. Analysts' revisions and market volatility are influencing investor sentiment.

$ARRYMed

ARRY Looks 56.4% Undervalued on GF Value™ Despite UBS Downgrade

Array Technologies (ARRY) fell 7.2% after UBS downgraded it to Neutral, cutting the price target from $10 to $5. UBS cited cash flow concerns due to dividend payments. ARRY's P/S ratio is 0.54, below historical and industry averages. GF Value™ suggests it's 56.4% undervalued, but the company has ongoing losses. GuruFocus' GF Score™ is 61/100, indicating moderate financial health. Institutional sentiment is mixed.

$ARRYHigh

Why is Array Technologies stock sliding today?

Array Technologies (ARRY) stock fell 3.1% to $4.11 in pre-market trading after UBS downgraded it to Neutral and cut its price target to $5 from $10, citing changes in preferred dividend obligations. UBS expects $162M in cash payments through 2030, impacting free cash flow. Piper Sandler also initiated coverage with a Neutral rating. The broader market is up, but ARRY's decline is company-specific.